Avid Bioservices Inc (CDMO)
10.49
+0.22
(+2.14%)
USD |
NASDAQ |
Nov 04, 13:05
Avid Bioservices Net Income (Quarterly): -5.534M for July 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -5.534M |
| April 30, 2024 | -123.10M |
| January 31, 2024 | -6.006M |
| October 31, 2023 | -9.521M |
| July 31, 2023 | -2.122M |
| April 30, 2023 | -0.335M |
| January 31, 2023 | -0.247M |
| October 31, 2022 | -0.52M |
| July 31, 2022 | 1.361M |
| April 30, 2022 | 115.60M |
| January 31, 2022 | 2.248M |
| October 31, 2021 | 3.522M |
| July 31, 2021 | 6.304M |
| April 30, 2021 | 1.991M |
| January 31, 2021 | 2.207M |
| October 31, 2020 | 2.284M |
| July 31, 2020 | 4.73M |
| April 30, 2020 | -4.768M |
| January 31, 2020 | -2.104M |
| October 31, 2019 | -0.43M |
| July 31, 2019 | -3.164M |
| April 30, 2019 | 0.336M |
| January 31, 2019 | -1.139M |
| October 31, 2018 | -1.451M |
| July 31, 2018 | -1.961M |
| Date | Value |
|---|---|
| April 30, 2018 | 3.02M |
| January 31, 2018 | -11.00M |
| October 31, 2017 | -12.62M |
| July 31, 2017 | -1.205M |
| April 30, 2017 | -5.272M |
| January 31, 2017 | -7.774M |
| October 31, 2016 | -4.056M |
| July 31, 2016 | -11.06M |
| April 30, 2016 | -11.88M |
| January 31, 2016 | -16.85M |
| October 31, 2015 | -13.20M |
| July 31, 2015 | -13.72M |
| April 30, 2015 | -12.14M |
| January 31, 2015 | -12.99M |
| October 31, 2014 | -12.10M |
| July 31, 2014 | -13.13M |
| April 30, 2014 | -10.25M |
| January 31, 2014 | -9.724M |
| October 31, 2013 | -7.79M |
| July 31, 2013 | -7.60M |
| April 30, 2013 | -8.449M |
| January 31, 2013 | -4.914M |
| October 31, 2012 | -8.753M |
| July 31, 2012 | -7.664M |
| April 30, 2012 | -10.88M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-123.10M
Minimum
Apr 2024
115.60M
Maximum
Apr 2022
-0.7377M
Average
-0.247M
Median
Jan 2023
Net Income (Quarterly) Benchmarks
| MEI Pharma Inc | -18.41M |
| Altimmune Inc | -24.64M |
| NovaBay Pharmaceuticals Inc | -1.585M |
| Palatin Technologies Inc | -8.250M |
| iBio Inc | -7.778M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 40.17M |
| Total Expenses (Quarterly) | 42.63M |
| EPS Diluted (Quarterly) | -0.09 |
| Enterprise Value | 775.66M |
| Gross Profit Margin (Quarterly) | 14.22% |
| Profit Margin (Quarterly) | -13.78% |
| Earnings Yield | -21.64% |
| Normalized Earnings Yield | -21.64 |